Model 1 (unadjusted) | Model 2 (adjusted by various comorbidities) | ||||||
---|---|---|---|---|---|---|---|
 | β | Standardized β (CI) | p-value |  | β | Standardized β (CI) | p-value |
ACAT1-Peritoneal Fluid | 0.006 | 1.006 (1.001–1.010) | 0.010 | BMI | 0.006 | 1.006 (1.001–1.010) | 0.010* |
Hyperlipidemia | 0.006 | 1.006 (1.001–1.011) | 0.010* | ||||
Obesity | 0.006 | 1.006 (1.001–1.010) | 0.014* | ||||
Diabetes | 0.008 | 1.008 (1.002–1.013) | 0.009* | ||||
Hypertension | 0.005 | 1.005 (1.001–1.010) | 0.019* | ||||
Hypothyroidism | 0.006 | 1.006 (1.001–1.010) | 0.014* | ||||
ACAT1-Tissue | 0.003 | 1.003 (1.001–1.005) | 0.009 | BMI | 0.003 | 1.003 (1.000–1.005) | 0.018* |
Hyperlipidemia | 0.003 | 1.003 (1.000–1.006) | 0.024* | ||||
Obesity | 0.003 | 1.005 (1.000–1.005) | 0.017* | ||||
Diabetes | 0.003 | 1.003 (1.000–1.005) | 0.026* | ||||
Hypertension | 0.003 | 1.005 (1.000–1.005) | 0.026* | ||||
Hypothyroidism | 0.003 | 1.006 (1.000–1.005) | 0.023* | ||||
CE- Peritoneal Fluid | 0.252 | 1.287 (1.026–1.614) | 0.029 | BMI | 0.256 | 1.292 (1.028–1.623) | 0.028* |
Hyperlipidemia | 0.255 | 1.291 (1.015–1.641) | 0.037* | ||||
Obesity | 0.254 | 1.289 (1.025–1.622) | 0.030* | ||||
Diabetes | 0.288 | 1.334 (1.041–1.711) | 0.023* | ||||
Hypertension | 0.269 | 1.309 (1.022–1.675) | 0.033* | ||||
Hypothyroidism | 0.243 | 1.275 (1.019–1.595) | 0.034* | ||||
CE-Tissue | 0.009 | 1.009 (1.001–1.019) | 0.041 | BMI | 0.010 | 1.010 (1.000–1.020) | 0.049* |
Hyperlipidemia | 0.011 | 1.011 (1.001–1.021) | 0.040* | ||||
Obesity | 0.010 | 1.010 (1.000–1.021) | 0.049* | ||||
Diabetes | 0.018 | 1.018 (0.999–1.038) | 0.067 | ||||
Hypertension | 0.011 | 1.011 (1.000–1.022) | 0.043* | ||||
Hypothyroidism | 0.011 | 1.011 (1.001–1.021) | 0.04* |